BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 212149)

  • 21. Responsiveness of the rat vas deferens to catecholamines and electrical stimulation during an infection with Trypanosoma brucei.
    Adeboye OO; Oriowo MA
    Afr J Med Med Sci; 1984; 13(3-4):135-8. PubMed ID: 6099973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of yohimbine on the contractile response of the mouse vas deferens to short, low frequency trains of nerve impulses.
    Karunanithi S; Lavidis NA; Bennett MR
    Eur J Pharmacol; 1994 Aug; 261(1-2):17-24. PubMed ID: 8001640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Action of various sympathomimetic amines on the isolated stripped vas deferens of the guinea-pig.
    Nedergaard OA; Westermann E
    Br J Pharmacol; 1968 Nov; 34(3):475-83. PubMed ID: 4302376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of cocaine and imipramine on tyramine-induced release of noradrenaline-3H from the rat vas deferens in vitro.
    Barnett A; Staub M; Symchowicz S
    Br J Pharmacol; 1969 May; 36(1):79-84. PubMed ID: 5768130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of depletion of the noradrenaline content on the response of the mouse vas deferens to electrical stimulation and to tyramine [proceedings].
    Marshall I; Nasmyth PA; Shepperson NB
    J Physiol; 1977 Feb; 265(1):45P-46P. PubMed ID: 850184
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of reserpine-induced depletion of noradrenaline on the negative feed-back mechanism for transmitter release during nerve stimulation.
    Enero MA; Langer SZ
    Br J Pharmacol; 1973 Oct; 49(2):214-25. PubMed ID: 4367125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High spatial resolution studies of muscarinic neuroeffector junctions in mouse isolated vas deferens.
    Cuprian-Beltechi AM; Solanki P; Teramoto N; Cunnane TC
    Neuroscience; 2009 Sep; 162(4):1366-76. PubMed ID: 19486927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a strong non-adrenergic component in the motor transmission to the rabbit vas deferens.
    Adebanjo AO; Ambache N
    West Afr J Pharmacol Drug Res; 1979; 5(1):95-105. PubMed ID: 45326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capsaicin enhances the non-adrenergic twitch response of rat vas deferens.
    Moritoki H; Iwamoto T; Kanaya J; Ishida Y; Ando K; Kitagawa K
    Br J Pharmacol; 1987 Oct; 92(2):469-75. PubMed ID: 2445407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The serotonin paradox: drug-receptor interaction in rat vas deferens.
    Jurkiewicz A; do Carmo LG; Yomura MH; Jurkiewicz NH
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(4):210-4. PubMed ID: 10797863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of noradrenaline release by peripheral presynaptic alpha 2-adrenoceptors in humans.
    Jie K; van Brummelen P; Vermey P; Timmermans PB; van Zwieten PA
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):407-13. PubMed ID: 2438503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opiate agonists inhibit noradrenaline release via opiate B-receptors and N-cyclopropylmethylnorazidomorphine (CAM) blocks electrically evoked contractions via histamine in the mouse vas deferens.
    Knoll J; Kerecsen L; Somogyi GT; Kovács A
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):52-65. PubMed ID: 6266359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action.
    Lenke D; Gries J; Kretzschmar R
    Arzneimittelforschung; 1981; 31(9a):1558-65. PubMed ID: 7197970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of postjunctional alpha1- and alpha2-adrenoceptor subtypes in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.
    Cleary L; Vandeputte C; Docherty JR
    Br J Pharmacol; 2003 Mar; 138(6):1069-76. PubMed ID: 12684262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An examination of factors influencing adrenergic transmission in the pithed rat, with special reference to noradrenaline uptake mechanisms and post-junctional alpha-adrenoceptors.
    Docherty JR; McGrath JC
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):101-11. PubMed ID: 6252478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of neuroeffector transmission in guinea-pig pulmonary artery and vas deferens by exogenous nitric oxide.
    Cederqvist B; Gustafsson LE
    Acta Physiol Scand; 1994 Jan; 150(1):75-81. PubMed ID: 8135125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors.
    Doxey JC; Smith CF; Walker JM
    Br J Pharmacol; 1977 May; 60(1):91-6. PubMed ID: 18248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of morphine on the release of noradrenaline from the mouse vas deferens.
    Henderson G; Hughes J
    Br J Pharmacol; 1976 Aug; 57(4):551-7. PubMed ID: 963343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens.
    Hughes J
    Br J Pharmacol; 1972 Mar; 44(3):472-91. PubMed ID: 4339251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that somatostatin releases endogenous substance(s) responsible for its presynaptic inhibitory effect on rat vas deferens and guinea pig ileum.
    Vizi ES; Horváth T; Somogyi GT
    Neuroendocrinology; 1984 Aug; 39(2):142-8. PubMed ID: 6147772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.